Accelerate your submissions with an AI-native platform and deep regulatory expertise
We are co-developing a suite of solutions to expedite regulatory submission preparation
Weave is a pioneer in AI-native regulatory automation management solutions. As a leading CRO design partner, Parexel will maintain a period of exclusivity as the only CRO to use Weave’s AI templates designed in partnership with Parexel.
Parexel has already leveraged Weave's flagship offering, AutoIND, to support Investigational New Drug (IND) applications, and has been able to complete them 50% faster than traditional IND authoring timelines. This efficiency provides a critical advantage in the time-sensitive process of launching new clinical trials. The AutoIND functionality is now integrated into The Weave Platform, Weave's comprehensive regulatory workflow solution that supports the entire regulatory lifecycle.
"We’re beginning this partnership by addressing an area where sponsors feel extreme urgency – early regulatory authoring and submission preparation. By combining Weave's cutting-edge AI technology with the human-in-the-lead expertise of Parexel Consulting, we're helping teams move faster and with greater confidence while maintaining the highest levels of quality and compliance.”
-Paul Bridges, Ph.D.
President of Parexel Consulting
Case Study
Utilizing AI to deliver regulatory documents faster
Situation
Solution
Key achievements
- Parexel sought to accelerate regulatory document preparation (particularly INDs) to help customers initiate clinical trials faster, as traditional authoring took 8-10 weeks.
- The traditional manual review process of numerous source documents with raw data created potential for human error and regulatory discrepancies that could delay approvals.
Situation
- Parexel sought to accelerate regulatory document preparation (particularly INDs) to help customers initiate clinical trials faster, as traditional authoring took 8-10 weeks.
- The traditional manual review process of numerous source documents with raw data created potential for human error and regulatory discrepancies that could delay approvals.
Solution
Key achievements